These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32103362)

  • 21. Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.
    Rensch F; Jonas JB; Spandau UH
    Acta Ophthalmol; 2009 Feb; 87(1):77-81. PubMed ID: 18937800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant.
    Winterhalter S; Vom Brocke GA; Pilger D; Eckert A; Schlomberg J; Rübsam A; Klamann MK; Gundlach E; Dietrich-Ntoukas T; Joussen AM
    BMC Ophthalmol; 2016 Oct; 16(1):187. PubMed ID: 27784291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion.
    Hung KH; Lee SM; Lee SY; Lee FL; Yang CS
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):85-90. PubMed ID: 20148661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal arteriovenous malformation presenting with retinal vein occlusion during pregnancy.
    Wester ST; Murray TG
    Retin Cases Brief Rep; 2010; 4(2):112-5. PubMed ID: 25390378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema.
    Battaglia Parodi M; Iacono P; Cascavilla ML; Zucchiatti I; Kontadakis DS; Vergallo S; Bandello F
    Eur J Ophthalmol; 2010; 20(6):1076-8. PubMed ID: 20954148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide].
    Le Moigne O; Duncombe A; Portmann A; Muraine M; Genevois O
    J Fr Ophtalmol; 2012 Nov; 35(9):700-4. PubMed ID: 22925843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report.
    Jeong S; Sagong M; Chang W
    BMC Ophthalmol; 2017 Mar; 17(1):25. PubMed ID: 28288603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Macular Neuroretinopathy Related to Alcoholic Hepatitis.
    Mc Cabe GA; Campbell WG; Campbell TG
    Case Rep Ophthalmol; 2021; 12(1):293-298. PubMed ID: 34054473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Background of a Recurrent Unusual Combined Form of Retinal Vein Occlusion: A Case Report.
    Bucan K; Plestina Borjan I; Bucan I; Paradzik Simunovic M; Borjan I
    Case Rep Ophthalmol; 2018; 9(1):248-253. PubMed ID: 29805379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
    Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ultra-low-molecular-weight heparin, fondaparinux, to treat retinal vein occlusion.
    Steigerwalt RD; Pascarella A; De Angelis M; Ciucci F; Gaudenzi F
    Drug Discov Ther; 2016; 10(3):167-71. PubMed ID: 27301712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
    Gado AS; Macky TA
    Clin Exp Ophthalmol; 2014; 42(7):650-5. PubMed ID: 24612095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions].
    Niederhauser N; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):405-8. PubMed ID: 23629792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report].
    Berkani Z; Kitouni Y; Belhadj A; Sifi K; Abbadi N; Bellatrache C; Hartani D; Kherroubi R
    J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practice.
    Wai KM; Khan M; Srivastava S; Rachitskaya A; Silva FQ; Deasy R; Schachat AP; Babiuch A; Ehlers JP; Kaiser PK; Yuan A; Singh RP
    Br J Ophthalmol; 2017 May; 101(5):574-579. PubMed ID: 27503394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.